Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context

Summary: Background: Evidence on post-acute sequelae of SARS-CoV-2 (PASC) has shown inconsistent findings. This study aimed to generate coherent evidence on the post-acute sequelae of COVID-19 infection using electronic healthcare records across two regions. Methods: In this retrospective, multi-da...

Full description

Bibliographic Details
Main Authors: Ivan Chun Hang Lam, Carlos King Ho Wong, Ran Zhang, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, Esther Wai Yin Chan, Hao Luo, Qingpeng Zhang, Kenneth Keng Cheung Man, Bernard Man Yung Cheung, Sydney Chi Wai Tang, Chak Sing Lau, Eric Yuk Fai Wan, Ian Chi Kei Wong
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023001773
_version_ 1797829100250857472
author Ivan Chun Hang Lam
Carlos King Ho Wong
Ran Zhang
Celine Sze Ling Chui
Francisco Tsz Tsun Lai
Xue Li
Esther Wai Yin Chan
Hao Luo
Qingpeng Zhang
Kenneth Keng Cheung Man
Bernard Man Yung Cheung
Sydney Chi Wai Tang
Chak Sing Lau
Eric Yuk Fai Wan
Ian Chi Kei Wong
author_facet Ivan Chun Hang Lam
Carlos King Ho Wong
Ran Zhang
Celine Sze Ling Chui
Francisco Tsz Tsun Lai
Xue Li
Esther Wai Yin Chan
Hao Luo
Qingpeng Zhang
Kenneth Keng Cheung Man
Bernard Man Yung Cheung
Sydney Chi Wai Tang
Chak Sing Lau
Eric Yuk Fai Wan
Ian Chi Kei Wong
author_sort Ivan Chun Hang Lam
collection DOAJ
description Summary: Background: Evidence on post-acute sequelae of SARS-CoV-2 (PASC) has shown inconsistent findings. This study aimed to generate coherent evidence on the post-acute sequelae of COVID-19 infection using electronic healthcare records across two regions. Methods: In this retrospective, multi-database cohort study, patients with COVID-19 aged 18 or above between April 1st 2020 and May 31st 2022 from the Hong Kong Hospital Authority (HKHA) and March 16th 2020 and May 31st 2021 from the UK Biobank (UKB) databases and their matched controls were followed for up to 28 and 17 months, respectively. Covariates between patients with COVID-19 and non-COVID-19 controls were adjusted using propensity score-based inverse probability treatment weighting. Cox proportional regression was used to estimate the hazard ratio (HR) of clinical sequelae, cardiovascular, and all-cause mortality 21 days after COVID-19 infection. Findings: A total of 535,186 and 16,400 patients were diagnosed with COVID-19 from HKHA and UKB, of whom 253,872 (47.4%) and 7613 (46.4%) were male, with a mean age (±SD) of 53.6 (17.8) years and 65.0 (8.5) years, respectively. Patients with COVID-19 incurred greater risk of heart failure (HR 1.82; 95% CI 1.65, 2.01), atrial fibrillation (1.31; 1.16, 1.48), coronary artery disease (1.32; 1.07, 1.63), deep vein thrombosis (1.74; 1.27, 2.37), chronic pulmonary disease (1.61; 1.40, 1.85), acute respiratory distress syndrome (1.89; 1.04, 3.43), interstitial lung disease (3.91; 2.36, 6.50), seizure (2.32; 1.12, 4.79), anxiety disorder (1.65; 1.29, 2.09), post-traumatic stress disorder (1.52; 1.23, 1.87), end-stage renal disease (1.76; 1.31, 2.38), acute kidney injury (2.14; 1.69, 2.71), pancreatitis (1.42; 1.10, 1.83), cardiovascular (2.86; 1.25, 6.51) and all-cause mortality (4.16; 2.11, 8.21) mortality during their post-acute phase of infection. Interpretation: The consistent greater risk of PASC highlighted the need for sustained multi-disciplinary care for COVID-19 survivors. Funding: Health Bureau, The Government of the Hong Kong Special Administrative Region, Collaborative Research Fund, The Government of the Hong Kong Special Administrative Region and AIR@InnoHK, administered by the Innovation and Technology Commission, The Government of the Hong Kong Special Administrative Region.
first_indexed 2024-04-09T13:15:03Z
format Article
id doaj.art-ced76f723438478e92eebba33007857e
institution Directory Open Access Journal
issn 2589-5370
language English
last_indexed 2024-04-09T13:15:03Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series EClinicalMedicine
spelling doaj.art-ced76f723438478e92eebba33007857e2023-05-12T04:17:01ZengElsevierEClinicalMedicine2589-53702023-06-0160102000Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in contextIvan Chun Hang Lam0Carlos King Ho Wong1Ran Zhang2Celine Sze Ling Chui3Francisco Tsz Tsun Lai4Xue Li5Esther Wai Yin Chan6Hao Luo7Qingpeng Zhang8Kenneth Keng Cheung Man9Bernard Man Yung Cheung10Sydney Chi Wai Tang11Chak Sing Lau12Eric Yuk Fai Wan13Ian Chi Kei Wong14Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, ChinaDepartment of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaLaboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong SAR, Hong Kong, China; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China; The University of Hong Kong Shenzhen Institute of Research and Innovation, Hong Kong SAR, ChinaDepartment of Social Work and Social Administration, The University of Hong Kong, Hong Kong SAR, China; The Hong Kong Jockey Club Centre for Suicide Research and Prevention, The University of Hong Kong, Hong Kong SAR, China; Sau Po Centre on Ageing, The University of Hong Kong, Hong Kong, ChinaSchool of Data Science, City University of Hong Kong, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; Research Department of Practice and Policy, School of Pharmacy, University College London, United KingdomDepartment of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Research Centre of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong, Queen Mary Hospital, Pok Fu Lam, Hong Kong, ChinaDivision of Nephrology, Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, ChinaDivision of Rheumatology and Clinical Immunology, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; Corresponding author. 3/F, Ap Lei Chau Clinic, 161 Ap Lei Chau Main Street, Ap Lei Chau, Hong Kong SAR, China.Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; Aston Pharmacy School, Aston University, Birmingham, United Kingdom; Corresponding author. L2-57, Laboratory Block, 21 Sassoon Road, Pokfulam, Hong Kong SAR, China.Summary: Background: Evidence on post-acute sequelae of SARS-CoV-2 (PASC) has shown inconsistent findings. This study aimed to generate coherent evidence on the post-acute sequelae of COVID-19 infection using electronic healthcare records across two regions. Methods: In this retrospective, multi-database cohort study, patients with COVID-19 aged 18 or above between April 1st 2020 and May 31st 2022 from the Hong Kong Hospital Authority (HKHA) and March 16th 2020 and May 31st 2021 from the UK Biobank (UKB) databases and their matched controls were followed for up to 28 and 17 months, respectively. Covariates between patients with COVID-19 and non-COVID-19 controls were adjusted using propensity score-based inverse probability treatment weighting. Cox proportional regression was used to estimate the hazard ratio (HR) of clinical sequelae, cardiovascular, and all-cause mortality 21 days after COVID-19 infection. Findings: A total of 535,186 and 16,400 patients were diagnosed with COVID-19 from HKHA and UKB, of whom 253,872 (47.4%) and 7613 (46.4%) were male, with a mean age (±SD) of 53.6 (17.8) years and 65.0 (8.5) years, respectively. Patients with COVID-19 incurred greater risk of heart failure (HR 1.82; 95% CI 1.65, 2.01), atrial fibrillation (1.31; 1.16, 1.48), coronary artery disease (1.32; 1.07, 1.63), deep vein thrombosis (1.74; 1.27, 2.37), chronic pulmonary disease (1.61; 1.40, 1.85), acute respiratory distress syndrome (1.89; 1.04, 3.43), interstitial lung disease (3.91; 2.36, 6.50), seizure (2.32; 1.12, 4.79), anxiety disorder (1.65; 1.29, 2.09), post-traumatic stress disorder (1.52; 1.23, 1.87), end-stage renal disease (1.76; 1.31, 2.38), acute kidney injury (2.14; 1.69, 2.71), pancreatitis (1.42; 1.10, 1.83), cardiovascular (2.86; 1.25, 6.51) and all-cause mortality (4.16; 2.11, 8.21) mortality during their post-acute phase of infection. Interpretation: The consistent greater risk of PASC highlighted the need for sustained multi-disciplinary care for COVID-19 survivors. Funding: Health Bureau, The Government of the Hong Kong Special Administrative Region, Collaborative Research Fund, The Government of the Hong Kong Special Administrative Region and AIR@InnoHK, administered by the Innovation and Technology Commission, The Government of the Hong Kong Special Administrative Region.http://www.sciencedirect.com/science/article/pii/S2589537023001773Post-acute sequelae of SARS-CoV-2PASCCOVID-19SARS-CoV-2
spellingShingle Ivan Chun Hang Lam
Carlos King Ho Wong
Ran Zhang
Celine Sze Ling Chui
Francisco Tsz Tsun Lai
Xue Li
Esther Wai Yin Chan
Hao Luo
Qingpeng Zhang
Kenneth Keng Cheung Man
Bernard Man Yung Cheung
Sydney Chi Wai Tang
Chak Sing Lau
Eric Yuk Fai Wan
Ian Chi Kei Wong
Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context
EClinicalMedicine
Post-acute sequelae of SARS-CoV-2
PASC
COVID-19
SARS-CoV-2
title Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context
title_full Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context
title_fullStr Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context
title_full_unstemmed Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context
title_short Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context
title_sort long term post acute sequelae of covid 19 infection a retrospective multi database cohort study in hong kong and the ukresearch in context
topic Post-acute sequelae of SARS-CoV-2
PASC
COVID-19
SARS-CoV-2
url http://www.sciencedirect.com/science/article/pii/S2589537023001773
work_keys_str_mv AT ivanchunhanglam longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT carloskinghowong longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT ranzhang longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT celineszelingchui longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT franciscotsztsunlai longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT xueli longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT estherwaiyinchan longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT haoluo longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT qingpengzhang longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT kennethkengcheungman longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT bernardmanyungcheung longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT sydneychiwaitang longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT chaksinglau longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT ericyukfaiwan longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext
AT ianchikeiwong longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext